| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/C5MB00711A |
| P8608 | Fatcat ID | release_gvmdvv63nrcyjamsaddo3kfdii |
| P698 | PubMed publication ID | 26883206 |
| P50 | author | Pär Jonsson | Q52001570 |
| Thomas Moritz | Q54656435 | ||
| Anna Wuolikainen | Q59573033 | ||
| P2093 | author name string | Miles Trupp | |
| Henrik Antti | |||
| Peter M Andersen | |||
| Stefan L Marklund | |||
| Maria Ahnlund | |||
| Lars Forsgren | |||
| P2860 | cites work | alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population | Q21136353 |
| Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II | Q24312770 | ||
| 2-Aminoadipic acid is a biomarker for diabetes risk | Q24617890 | ||
| Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis | Q26863439 | ||
| ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy | Q28114784 | ||
| The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations | Q28274011 | ||
| Metabolite profiling of Alzheimer's disease cerebrospinal fluid | Q28480903 | ||
| The role of autophagy in neurodegenerative disease | Q29614834 | ||
| Exenatide and the treatment of patients with Parkinson's disease | Q30540208 | ||
| Mass spectrometry-based metabolomics | Q33254576 | ||
| Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol | Q33769607 | ||
| Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. | Q33869419 | ||
| Polyol pathway and diabetic peripheral neuropathy | Q34800429 | ||
| Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease | Q35040454 | ||
| Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway | Q35754540 | ||
| Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling | Q35886625 | ||
| Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples | Q36162272 | ||
| Risk of dementia in diabetes mellitus: a systematic review | Q36345254 | ||
| Metabolomic analysis and signatures in motor neuron disease | Q36908588 | ||
| Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways | Q37188890 | ||
| Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model | Q37285915 | ||
| Metabolomics: moving to the clinic | Q37462435 | ||
| Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease | Q37671390 | ||
| EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force | Q37931374 | ||
| Clinical genetics of amyotrophic lateral sclerosis: what do we really know? | Q37944428 | ||
| Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. | Q37972903 | ||
| Excitotoxicity: bridge to various triggers in neurodegenerative disorders | Q38057521 | ||
| Looking back into the future: 30 years of metabolomics at TNO. | Q38102969 | ||
| Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome | Q38195470 | ||
| Defective autophagy in Parkinson's disease: lessons from genetics | Q38225786 | ||
| Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism | Q38832035 | ||
| Requirement for lysosomal localization of mTOR for its activation differs between leucine and other amino acids | Q38998941 | ||
| Metabolism. Differential regulation of mTORC1 by leucine and glutamine | Q39211265 | ||
| Untargeted 1H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease | Q39241061 | ||
| ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations. | Q39661561 | ||
| A clinical trial of creatine in ALS. | Q40469445 | ||
| Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease | Q42548051 | ||
| Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosis | Q43091395 | ||
| Impaired glucose tolerance in patients with amyotrophic lateral sclerosis | Q43149662 | ||
| Hypermetabolism in ALS: correlations with clinical and paraclinical parameters | Q43688446 | ||
| Family history of neurodegenerative and vascular diseases in ALS: a population-based study | Q43909051 | ||
| Extraction and GC/MS analysis of the human blood plasma metabolome | Q46849028 | ||
| Familial aggregation of Parkinson's disease in the Faroe Islands. | Q48370351 | ||
| Kynurenine pathway abnormalities in Parkinson's disease. | Q48434372 | ||
| 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis. | Q50732857 | ||
| Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. | Q51071299 | ||
| Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes? | Q56049682 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Principal component analysis | Q56763826 | ||
| OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification | Q58045925 | ||
| Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS | Q58125385 | ||
| High metabolic level in patients with familial amyotrophic lateral sclerosis | Q58125394 | ||
| Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration | Q69503377 | ||
| Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease | Q88076090 | ||
| P433 | issue | 4 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| amyotrophic lateral sclerosis | Q206901 | ||
| P304 | page(s) | 1287-1298 | |
| P577 | publication date | 2016-02-17 | |
| P1433 | published in | Molecular BioSystems | Q3319467 |
| P1476 | title | Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects | |
| P478 | volume | 12 |
| Q114783473 | A Set of Reliable Samples for the Study of Biomarkers for the Early Diagnosis of Parkinson's Disease |
| Q64269328 | A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS |
| Q92259889 | A comprehensive protocol for multiplatform metabolomics analysis in patient-derived skin fibroblasts |
| Q89922975 | A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis |
| Q50045364 | A glimmer of light at the end of the tunnel? |
| Q98194013 | Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients |
| Q93164263 | An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders |
| Q90691805 | Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease |
| Q41666702 | Biomarker Research in Parkinson's Disease Using Metabolite Profiling |
| Q51299341 | Biomarker discovery using dry-lab technologies and high-throughput screening. |
| Q64079969 | Biomarkers in Motor Neuron Disease: A State of the Art Review |
| Q96585609 | Blood Biomarkers and Prognosis of Amyotrophic Lateral Sclerosis |
| Q100532384 | Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders |
| Q101063032 | Brain energy metabolism and multiple sclerosis: progress and prospects |
| Q102335828 | Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways |
| Q98297801 | Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson's Disease: review and meta-analysis |
| Q64788297 | Cerebrospinal fluid biomarker for Parkinson's disease: An overview |
| Q38719357 | Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia. |
| Q61796431 | Chronic sleep restriction in the rotenone Parkinson's disease model in rats reveals peripheral early-phase biomarkers |
| Q100409450 | Circulating Metabolites as Potential Biomarkers for Neurological Disorders-Metabolites in Neurological Disorders |
| Q50027150 | Current state of bioanalytical chromatography in clinical analysis. |
| Q38639708 | Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease. |
| Q91811242 | Existing and Emerging Metabolomic Tools for ALS Research |
| Q39033841 | Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis |
| Q96683446 | Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis |
| Q33799643 | Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study |
| Q101117355 | LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson's Disease and Parkinsonian Syndromes Patients |
| Q97523046 | Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes |
| Q55237897 | Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43. |
| Q50066234 | Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities. |
| Q94955915 | Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-L-Alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral Sclerosis |
| Q51288392 | Metabolite Profiling of LADA Challenges the View of a Metabolically Distinct Subtype. |
| Q47211940 | Metabolite profiling of obese individuals before and after a one year weight loss program |
| Q60304733 | Metabolomic investigations in cerebrospinal fluid of Parkinson's disease |
| Q60949835 | Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS |
| Q92754789 | Metabolomics analysis of Camellia sinensis with respect to harvesting time |
| Q38616672 | Metabolomics for Plant Improvement: Status and Prospects |
| Q54969000 | Metabolomics of Hydrazine-Induced Hepatotoxicity in Rats for Discovering Potential Biomarkers. |
| Q87872586 | Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective |
| Q50090010 | Metabolomics toward personalized medicine. |
| Q41515229 | Multivariate strategy for the sample selection and integration of multi-batch data in metabolomics |
| Q90329666 | Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy |
| Q61807813 | Polymorphisms of -, , and - Are Not Associated with Parkinson's Disease in Taiwan |
| Q93079386 | Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis |
| Q51761574 | Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease. |
| Q101561656 | Qualitative and Quantitative Analysis of Regional Cerebral Free Fatty Acids in Rats Using the Stable Isotope Labeling Liquid Chromatography-Mass Spectrometry Method |
| Q48043375 | Serum amino acid profile in patients with Parkinson's disease |
| Q96618576 | Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis |
| Q98730855 | Shared perturbations in the metallome and metabolome of Alzheimer's, Parkinson's, Huntington's, and dementia with Lewy bodies: a systematic review |
| Q91265039 | Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS |
| Q60957114 | The Metabolome and Osteoarthritis: Possible Contributions to Symptoms and Pathology |
| Q112107322 | The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson's Disease Patients |
| Q88500156 | Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels |
| Q99417290 | Untargeted metabolomics yields insight into ALS disease mechanisms |
| Q100387918 | Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis |
| Q48851536 | Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. |
Search more.